USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Korea Institute OF Oriental Medicine

USPTO PatentsView assignee record - 36 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Korea ranks #8,851 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 22 technology areas.

#8,851
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.3/100)
9.8
avg claims per patent
-33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8851 · Foreign Corporation #8,851 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 36 grants
  • UPPER-Q #8,851/49,997
  • PHOTO-FINISH Janssen Pharmaceutic…
  • CPC-FOCUS A61K · 22 areas
  • INNOV-PAR 40.3/100
  • CLAIMS-PAR 9.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Janssen Pharmaceutica NA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Korea’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Korea

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Korea's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Korea?

Each dot is one of Korea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Korea’s own 9.8 claims/patent is at or below the 12.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Korea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 35.936.036.03636.036.036.1 0510152025 Granted patents (volume) Avg claims / patent Janssen Pharmaceutica NA - 36, 12.22Janssen Pharmaceu…Jazz Pharmaceuticals Ireland Limited - 36, 20.64Jazz Pharmaceutic…KE.COM (BEIJING) Technology Co., Ltd. - 36, 7.42KE COM (Beijing)…Kodiak Networks Inc - 36, 22.39Kodiak NetworksKose Corporation - 36, 4.56KoseKenu, Inc. - 36, 3.39KenuLeggett & Platt Canada Co. - 36, 19.39Leggett & Platt C…Lifeline Scientific, Inc. - 36, 15.56Lifeline Scientif…Korea Institute OF Oriental Medicine - 36, 9.78Korea Institute O…
Korea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Korea's grants concentrate

Korea Institute OF Oriental Medicine is a focused PatentsView assignee: 22 CPC subclasses with 72.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (7 grants) versus a trough of 1 in 2018. By volume, Korea sits between Janssen Pharmaceutica NA and Lifeline Scientific, Inc..

Korea's three-year grant acceleration

Korea Institute OF Oriental Medicine shows 8 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Korea's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Korea holds 36 patents at rank #8,849, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Korea

By rank, the assignees closest to #8,849 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Korea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Korea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Korea ranks #871 of 7,163 assignees by patent count in that subclass.

Korea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Korea Institute OF Oriental Medicine patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 8.3%
2016 7 19.4%
2017 6 16.7%
2018 1 2.8%
2019 4 11.1%
2020 3 8.3%
2021 3 8.3%
2022 3 8.3%
2023 2 5.6%
2024 3 8.3%
2025partial year 1 2.8%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Korea Institute OF Oriental Medicine's patent record in context - here's where to go next.

  • Korea Institute OF Oriental Medicine's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 72.2% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #8,851 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Korea Institute OF Oriental Medicine against Janssen Pharmaceutica NA, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.